This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Talukder, A. H. Articles by Kumar, R. Search for Related Content PubMed PubMed Citation Articles by Talukder, A. H. Articles by Kumar, R.

Heregulin Induces Expression, DNA Binding Activity, and Transactivating Functions of Basic Leucine Zipper Activating Transcription Factor 4¹

The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Heregulin ß1 (HRG), a combinatorial ligand for human epidermal growth factor receptor 3 and human epidermal growth factor receptor 4 receptors, is a regulatory secretory polypeptide with distinct biological effects such as growth stimulation, differentiation, invasiveness, and migration in breast cancer cells. The mechanism underlying the diverse functions of HRG is not well established, but it is believed to be dependent on the induced changes in expression of specific cellular gene products, their modification, or both. The binding of basic leucine zipper transcription factors to the cAMP response element is known to activate a variety of gene products with a role or roles in growth regulation. In the studies presented here, we identified basic leucine zipper activating transcription factor (ATF) 4 as one of the HRG-inducible gene product. We demonstrated that HRG stimulation of human cancer cells induces expression of ATF4 mRNA and protein, ATF4 DNA binding activity, and ATF4 transactivating function. Consistent with its role as a transcriptional activator, HRG-stimulated ATF4 protein stimulated the transcription from an artificial promoter with three tandem ATF sites or from a naturally occurring promoter with ATF4 sites such as E-selectin. We also demonstrated a preferential role of the HRG-stimulated mitogen-activated protein kinase pathway, but not the phosphatidylinositol 3'-kinase pathway, in supporting the observed increase in ATF4 DNA binding activity and transcription from E-selectin promoter in HRG-stimulated cells. Because ATF4 binding sites are present in a variety of growth-regulating cellular genes, these findings suggest that the stimulation of ATF4 expression and its transactivating functions may constitute an important mechanism of HRG-mediated regulation of putative genes with diversified functions. The present study is the first demonstration of regulation of expression and transactivation ability of ATF4 by any polypeptide growth factor.

This article has been cited by other articles:

				Y. Zhang and A. W. Hamburger Heregulin Regulates the Ability of the ErbB3-binding Protein Ebp1 to Bind E2F Promoter Elements and Repress E2F-mediated Transcription J. Biol. Chem., June 18, 2004; 279(25): 26126 - 26133. [Abstract] [Full Text] [PDF]

				R. Bagheri-Yarmand, R. K. Vadlamudi, and R. Kumar Activating Transcription Factor 4 Overexpression Inhibits Proliferation and Differentiation of Mammary Epithelium Resulting in Impaired Lactation and Accelerated Involution J. Biol. Chem., May 2, 2003; 278(19): 17421 - 17429. [Abstract] [Full Text] [PDF]

				G. Zanazzi, S. Einheber, R. Westreich, M.-J. Hannocks, D. Bedell-Hogan, M. A. Marchionni, and J. L. Salzer Glial Growth Factor/Neuregulin Inhibits Schwann Cell Myelination and Induces Demyelination J. Cell Biol., March 19, 2001; 152(6): 1289 - 1300. [Abstract] [Full Text] [PDF]